Make Cardiovascular Disease a Named Line in the Health Budget: A Primary-Care-First Plan for Bangladesh

Diagnosis

Cardiovascular disease (CVD) is now the largest single driver of mortality in Bangladesh. The curated assessment puts it at roughly 30% of all deaths, alongside a rising young-adult myocardial infarction (MI) rate. Two features make this a tier-one structural problem rather than a slow demographic drift. First, a near one-in-three share of deaths means CVD is no longer a specialist hospital issue, it is a primary-care and population-health issue that the system is not organized to catch. Second, the rising young-adult MI rate signals that risk is moving earlier in the life course, into the working-age population that the economy depends on. A death or disabling event in a person's productive years carries a far larger economic and household cost than one at the end of life.

The system today is built to treat acute cardiac events in tertiary hospitals, not to detect and manage hypertension and metabolic risk years earlier in the upazila and union facilities where most people first touch the health system. That mismatch is the root cause: the burden is upstream, the capacity is downstream.

Recommended actions

1. Owner: Directorate General of Health Services (DGHS). Mechanism: issue a national operational circular standing up opportunistic blood-pressure and risk screening at every union and upazila facility, with a single protocol-based treatment algorithm and a guaranteed supply of generic antihypertensive and statin medicines through the existing essential drug list. Observable signal: the share of attending adults screened for blood pressure rises month over month, and stockout reports for first-line CVD medicines fall toward zero.
2. Owner: DGHS. Mechanism: create a dedicated CVD and NCD line item in the directorate's annual budget submission so screening, medicines, and community health-worker time are funded explicitly rather than absorbed into general primary care. Observable signal: a named, ring-fenced CVD allocation appears in the next budget cycle and is disbursed, not just appropriated.
3. Owner: DGHS. Mechanism: stand up a simple CVD surveillance register inside the existing health information system, tracking new hypertension diagnoses, treatment continuation, and acute MI presentations by age band. Observable signal: a quarterly dashboard reports young-adult MI counts and screening coverage, replacing the current absence of routine numbers.
4. Owner: DGHS, supported by the Department of Public Health Engineering. Mechanism: a joint working protocol that links environmental risk reduction (drinking-water quality and salinity, which raise blood pressure) to the CVD screening rollout, so high-salinity catchments are prioritized for both screening and water remediation. Observable signal: priority catchments are jointly mapped and screening coverage in them rises faster than the national average.
5. Owner: DGHS. Mechanism: a workforce directive enrolling existing community health workers as the front line for blood-pressure follow-up and treatment adherence, with a referral pathway to upazila health complexes for confirmed cases. Observable signal: treatment continuation rates among diagnosed patients climb across successive quarters.

Sequencing (first 12 months)

Start with the DGHS screening circular and the medicines supply guarantee, because detection without treatment erodes trust and a treatment promise without drugs fails on first contact. These two together create the demand and the data that justify the budget line. In parallel, stand up the surveillance register so the program can show coverage and the young-adult MI trend from month one. The DGHS and Department of Public Health Engineering environmental protocol can follow once screening identifies where the highest-risk catchments are, because the register tells you where to point it.

Risks and constraints

The binding constraint is fiscal and organizational, not clinical. Without a ring-fenced CVD line in the DGHS budget, screening competes with every other primary-care demand and loses. The second constraint is supply chain: a screening drive that surfaces patients the system cannot medicate will generate diagnosed, untreated hypertension and damage credibility. The third is workforce: community health workers are already stretched, so adding CVD follow-up requires explicit task definition and is not free. Political attention also skews toward visible tertiary cardiac facilities rather than unglamorous primary-care detection, which is where the larger share of the 30% can actually be moved.

Bottom line

Cardiovascular disease at roughly 30% of deaths, with a rising young-adult MI rate, is a primary-care failure that is being treated as a hospital problem. DGHS can bend the curve by funding a named CVD budget line, guaranteeing first-line medicines, and pushing protocol-based screening to the union level, with the Department of Public Health Engineering tackling the environmental risk underneath.